The Biological Functions and Mode of Action of Transcription Factor ELF4: A Promising Target for Treating Intestinal Homeostasis Disorder-Related Diseases
Open Access
Abstract
Intestinal homeostasis disorders (IHDs), driven by food safety issues, pollution, and drug-resistant pathogens, threaten global health. Key factors in intestinal and metabolic diseases (like IBD, obesity, and liver disease) include barrier dysfunction, gut microbiota imbalance, and excessive immune activation. Transcription factors in intestinal epithelial cells are crucial regulators. ELF4, an ETS family transcription factor, plays vital roles in transcriptional regulation, impacting tumorigenesis, the DNA damage response, and the cell cycle. ELF4 deficiency exacerbates alcoholic liver disease (ALD). Significantly, ELF4 is a novel IFN-I transcription factor with antiviral capabilities. Its regulation of the type I IFN response offers new avenues for developing antiviral and anticancer strategies and managing IFN-induced autoimmune disorders. Thus, ELF4 emerges as a promising target for preventing and treating IHD-related diseases. Mechanistic studies could help identify diets or antimicrobials that activate intestinal ELF4 to combat pathogen/virus-induced intestinal diseases.Keywords
Funding Information
- National Natural Science Foundation of China (32402807)
- Chongqing Technology Innovation and Application Development Special Project (cstc2021jscx dxwtBX0005)
This publication has 156 references indexed in Scilit:
- Advances in pig models of human diseasesAnimal Models and Experimental Medicine, 2022
- Loss of Function Mutation in ELF4 Causes Autoinflammatory and Immunodeficiency Disease in HumanJournal of Clinical Immunology, 2022
- Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert CommitteeJournal of Clinical Immunology, 2020
- Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical ClassificationJournal of Clinical Immunology, 2020
- Bridging intestinal immunity and gut microbiota by metabolitesCellular and Molecular Life Sciences, 2019
- Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in miceHepatology, 2014
- Transcription factor ELF4 promotes development and function of memory CD8+T cells in Listeria monocytogenes infectionEuropean Journal of Immunology, 2013
- Osteoblast–adipocyte lineage plasticity in tissue development, maintenance and pathologyCellular and Molecular Life Sciences, 2013
- The mucosal firewalls against commensal intestinal microbesSeminars in Immunopathology, 2009
- The suppressive effect of myeloid elf‐1‐like factor (MEF) in osteogenic differentiationJournal of Cellular Physiology, 2006